Cargando…

Changes in lipoprotein lipase and endothelial lipase mass in familial hypercholesterolemia during three-drug lipid-lowering combination therapy

BACKGROUND: This study was performed to compare the effects of three different lipid-lowering therapies (statins, ezetimibe, and colestimide) on lipoprotein lipase and endothelial lipase masses in pre-heparin plasma (pre-heparin LPL and EL mass, respectively) from patients with familial hypercholest...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tada, Hayato, Kobayashi, Junji, Kawashiri, Masa-aki, Miyashita, Kazuya, Nohara, Atsushi, Inazu, Akihiro, Nakajima, Katsuyuki, Mabuchi, Hiroshi, Yamagishi, Masakazu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818918/ https://www.ncbi.nlm.nih.gov/pubmed/27039080 http://dx.doi.org/10.1186/s12944-016-0238-z

Ejemplares similares

Lipoprotein metabolism in familial hypercholesterolemia: Serial assessment using a one-step ultracentrifugation method
por: Tada, Hayato, et al.
Publicado: (2015)

Post-prandial Remnant Lipoprotein Metabolism in Sitosterolemia
por: Tada, Hayato, et al.
Publicado: (2018)

Sitosterolemia, Hypercholesterolemia, and Coronary Artery Disease
por: Tada, Hayato, et al.
Publicado: (2018)

Oral Fat Tolerance Test for Sitosterolemia and Familial Hypercholesterolemia: A Study Protocol
por: Nomura, Akihiro, et al.
Publicado: (2018)

Lipid Management in a Japanese Community: Attainment Rate of Target Set by the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases 2012
por: Tada, Hayato, et al.
Publicado: (2017)

Aortic Root Calcification Score as an Independent Factor for Predicting Major Adverse Cardiac Events in Familial Hypercholesterolemia
por: Okada, Hirofumi, et al.
Publicado: (2018)

Synergistic effect of lipoprotein (a) and C-reactive protein on prognosis of familial hypercholesterolemia
por: Tada, Hayato, et al.
Publicado: (2022)

Impact of genetic testing on low-density lipoprotein cholesterol in patients with familial hypercholesterolemia (GenTLe-FH): a randomised waiting list controlled open-label study protocol
por: Nomura, Akihiro, et al.
Publicado: (2018)

Which is the Best Predictor for the Development of Atherosclerosis Among Circulating Lipoprotein Lipase, Hepatic Lipase, and Endothelial Lipase?
por: Kobayashi, Junji
Publicado: (2019)

Impact of the severe familial hypercholesterolemia status on atherosclerotic risks
por: Tada, Hayato, et al.
Publicado: (2023)

Lipoprotein lipase is active as a monomer
por: Beigneux, Anne P., et al.
Publicado: (2019)

Individualized Treatment for Patients With Familial Hypercholesterolemia
por: Tada, Hayato, et al.
Publicado: (2022)

Early diagnosis and treatments in childhood are associated with better prognosis in patients with familial hypercholesterolemia
por: Tada, Hayato, et al.
Publicado: (2022)

A reassessment of the Japanese clinical diagnostic criteria of familial hypercholesterolemia in a hospital-based cohort using comprehensive genetic analysis
por: Tada, Hayato, et al.
Publicado: (2020)

Effects of Different Types of Pathogenic Variants on Phenotypes of Familial Hypercholesterolemia
por: Tada, Hayato, et al.
Publicado: (2022)

Impact of Healthy Lifestyle in Patients With Familial Hypercholesterolemia
por: Tada, Hayato, et al.
Publicado: (2023)

Prevalence, self-awareness, and LDL cholesterol levels among patients highly suspected as familial hypercholesterolemia in a Japanese community
por: Tada, Hayato, et al.
Publicado: (2020)

Achilles Tendon Thickness Assessed by X-ray Predicting a Pathogenic Mutation in Familial Hypercholesterolemia Gene
por: Tada, Hayato, et al.
Publicado: (2022)

Children with Severe Hypercholesterolemia Caused by a Pathogenic Mutation in ABCG5
por: Tada, Hayato, et al.
Publicado: (2022)

Clinical Perspectives of Genetic Analyses on Dyslipidemia and Coronary Artery Disease
por: Tada, Hayato, et al.
Publicado: (2017)

Serum Triglycerides and Atherosclerotic Cardiovascular Disease: Insights from Clinical and Genetic Studies
por: Tada, Hayato, et al.
Publicado: (2018)

Familial Hypercholesterolemia: A Narrative Review on Diagnosis and Management Strategies for Children and Adolescents
por: Tada, Hayato, et al.
Publicado: (2021)

Whole Exome Sequencing Insufficient for a Definitive Diagnosis of a Patient with Compound Heterozygous Familial Hypercholesterolemia
por: Okada, Hirofumi, et al.
Publicado: (2022)

Targeted Panel Sequencing will Boost Detection of Genetic Backgrounds of Familial Hypercholesterolemia in the World's Most Populous Country
por: Tada, Hayato, et al.
Publicado: (2020)

Case report: Unusual coexistence between familial hypercholesterolemia and familial hypobetalipoproteinemia
por: Sasaki, Kei, et al.
Publicado: (2022)

Function and Immunogenicity of Gene-corrected iPSC-derived Hepatocyte-Like Cells in Restoring Low Density Lipoprotein Uptake in Homozygous Familial Hypercholesterolemia
por: Okada, Hirofumi, et al.
Publicado: (2019)

Species differences in lipoprotein lipase and hepatic lipase activities: comparative studies of animal models of lifestyle-related diseases
por: Kimura, Norie, et al.
Publicado: (2019)

Associations between questionnaires on lifestyle and atherosclerotic cardiovascular disease in a Japanese general population: A cross-sectional study
por: Tada, Hayato, et al.
Publicado: (2018)

Comparative Analyses of Lipoprotein Lipase, Hepatic Lipase, and Endothelial Lipase, and Their Binding Properties with Known Inhibitors
por: Wang, Ziyun, et al.
Publicado: (2013)

Lipoprotein(a) as an Old and New Causal Risk Factor of Atherosclerotic Cardiovascular Disease
por: Tada, Hayato, et al.
Publicado: (2019)

A Healthy Family of Familial Hypobetalipoproteinemia Caused by a Protein-truncating Variant in the PCSK9 Gene
por: Tada, Hayato, et al.
Publicado: (2020)

Impact of serum levels of lipoprotein lipase, hepatic lipase, and endothelial lipase on the progression of coronary artery disease
por: Han, Hui, et al.
Publicado: (2019)

Electrostatic sheathing of lipoprotein lipase is essential for its movement across capillary endothelial cells
por: Song, Wenxin, et al.
Publicado: (2022)

The Assessment of Carotid Atherosclerotic Plaque among Young Patients with Familial Hypercholesterolemia
por: Shibayama, Junichi, et al.
Publicado: (2022)

Sitosterolemia Exhibiting Severe Hypercholesterolemia with Tendon Xanthomas Due to Compound Heterozygous ABCG5 Gene Mutations Treated with Ezetimibe and Alirocumab
por: Tanaka, Hiroki, et al.
Publicado: (2020)

Association between skeletal muscle mass and serum concentrations of lipoprotein lipase, GPIHBP1, and hepatic triglyceride lipase in young Japanese men
por: Matsumoto, Ryutaro, et al.
Publicado: (2019)

Genetic Analysis of Japanese Children Clinically Diagnosed with Familial Hypercholesterolemia
por: Nagahara, Keiko, et al.
Publicado: (2022)

Pitavastatin versus Atorvastatin: Potential Differences in their Effects on Serum Lipoprotein Lipase and Cardiovascular Disease
por: Kobayashi, Junji
Publicado: (2022)

Role of Hepatic Lipase and Endothelial Lipase in High-Density Lipoprotein—Mediated Reverse Cholesterol Transport
por: Annema, Wijtske, et al.
Publicado: (2011)

Impact of Aging on High-sensitivity Cardiac Troponin T in Patients Suspected of Acute Myocardial Infarction
por: Ichise, Taro, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_cuo4j04eo8dbg0o9lbkel77ggg